Table 3.
Quality assessment of studies on transcriptomic analyses to identify distinct subtypes of EAC.
Author | Retrospective or Prospective | Number Independent EAC Cases | Quality Assessment of RNA | Tumor Percentage | Independent Cohort Validation | Overall Recommendation Level (+, +/−, −) |
---|---|---|---|---|---|---|
TCGA, Australia, Brazil, Canada, Germany, South-Korea, Moldova, Netherlands, Poland, Russia, Ukraine United Kingdom, United States of America, Vietnam [31] | Retrospective | 72 | RNA Integrity ≥ 7.0 | ≥60% tumor nuclei | No | − |
Bornschein, United Kingdom, Germany [33] | Retrospective | 84 | RNA integrity number (RIN) > 7.0 | ≥70% tumor cellularity | Yes | +/− |
Kim, United States of America [34] | Retrospective | 64 | RNA quality index (>7) | NA | Only for sub-selection of genes | − |